MYD88 and bacterial infectious disease with sepsis: Additionally, animal survival was improved and bacteremia was attenuated in the MyD88-/- (100%, Fig 3A and 3B) and TLR2-/- (100%, Fig 3C and 3D) mice in comparison with the irinotecan-injected WT mice (P<0.05).